Device-associated hospital-acquired infections in a tertiary cardiac hospital in northern Iran: A six-year retrospective study
DOI:
https://doi.org/10.66224/jcbior.7.2.353Keywords:
Device-associated infection, Healthcare-associated infection, Catheter-related infection, Cardiac hospitalAbstract
Device-associated healthcare-associated infections (DA-HAIs) remain a major challenge in hospitalized patients, particularly among those requiring invasive medical devices. This study aimed to describe the epidemiological characteristics, distribution of causative microorganisms, and clinical outcomes of DA-HAIs in a tertiary cardiac hospital in northern Iran. In this retrospective descriptive study, hospital records and infection surveillance data of patients with DA-HAIs were reviewed from March 21, 2018, to March 21, 2024. Eligible cases included hospitalized patients with documented exposure to invasive devices, including urinary catheters, vascular devices, or mechanical ventilation. Demographic characteristics, hospitalization-related variables, device-associated infection types, microbiological findings, and in-hospital outcomes were collected using a structured data extraction. A total of 320 episodes of DA-HAIs were identified. The median age of affected patients was 67 years (IQR: 59–75), and 67.5% were female. Catheter-associated urinary tract infection (CAUTI) was the most frequent infection type, accounting for 88.1% of cases, followed by ventilator-associated events/pneumonia (9.1%), peripheral intravenous catheter-associated bloodstream infections (1.9%), and central line-associated bloodstream infections (0.9%). Escherichia coli was the predominant microorganism, responsible for 57.5% of all isolates, with Gram-negative bacteria representing the majority of identified pathogens. Overall, 42 patients (13.1%) died during hospitalization. This study demonstrates a substantial burden of DA-HAIs in a tertiary cardiac hospital, characterized by a predominance of CAUTI and Gram-negative bacterial pathogens. Continuous device-associated infection surveillance, optimization of device utilization, and targeted infection prevention strategies are essential to reduce the clinical impact of these infections in specialized cardiac care settings.
References
1. Alshagrawi S, Alhodaithy N. Risk factors of healthcare-associated infection among healthcare workers in intensive care units: A multicenter cross-sectional study. PLoS One. 2024;19(12):e0314796
DOI: 10.1371/journal.pone.0314796 PMID: 39689140
2. Rosenthal VD, Maki DG, Mehta Y, Leblebicioglu H, Memish ZA, Al-Mousa HH, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module. Am J Infect Control. 2014;42(9):942-56
DOI: 10.1016/j.ajic.2014.05.029 PMID: 25179325
3. Odoom A, Donkor ES. Prevalence of Healthcare-Acquired Infections Among Adults in Intensive Care Units: A Systematic Review and Meta-Analysis. Health Sci Rep. 2025;8(7):e70939 DOI: 10.1002/hsr2.70939 PMID: 40636544
4. Khan ID, Basu A, Kiran S, Trivedi S, Pandit P, Chattoraj A. Device-Associated Healthcare-Associated Infections (DA-HAI) and the caveat of multiresistance in a multidisciplinary intensive care unit. Med J Armed Forces India. 2017;73(3):222-231
DOI: 10.1016/j.mjafi.2016.10.008 PMID: 28790779
5. Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377(9761):228-41
DOI: 10.1016/S0140-6736(10)61458-4 PMID: 21146207
6. Guarente L, Mosconi C, Cicala M, De Santo C, Ciccacci F, Carestia M, et al. Device associated healthcare associated infection (DA-HAI): a detailed analysis of risk factors and outcomes in a university hospital in Rome, Italy. Infect Prev Pract. 2024;6(4):100391
DOI: 10.1016/j.infpip.2024.100391 PMID: 39329082
7. Blot S, Ruppé E, Harbarth S, Asehnoune K, Poulakou G, Luyt CE, et al. Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive Crit Care Nurs. 2022;70:103227
DOI: 10.1016/j.iccn.2022.103227 PMID: 35249794
8. Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006;145(8):582-91 DOI: 10.7326/0003-4819-145-8-200610170-00007 PMID: 17043340
9. Fakir AA, Patil SR, Mane PM. Medical Device-Associated Infections in Intensive Care Settings: Biofilms, Multidrug-Resistant Pathogens, and Prevention Strategies. Cureus. 2026;18(7):e111893
DOI: 10.7759/cureus.111893 PMID: 42540543
10. Afhami S, Seifi A, Hajiabdolbaghi M, Bazaz NE, Hadadi A, Hasibi M, et al. Assessment of device-associated infection rates in teaching hospitals in Islamic Republic of Iran. East Mediterr Health J. 2019;25(2):90-97
DOI: 10.26719/emhj.18.015 PMID: 30942472
11. Izadi N, Eshrati B, Etemad K, Mehrabi Y, Hashemi-Nazari SS. Rate of the incidence of hospital-acquired infections in Iran based on the data of the national nosocomial infections surveillance. New Microbes New Infect. 2020;38:100768
DOI: 10.1016/j.nmni.2020.100768 PMID: 33093962
12. Vîrtosu DM, Munteanu Dragomir A, Crișan S, Luca S, Pătru O, Băghină RM, et al. Prevalence of Healthcare-Associated Infections in Patients with Cardiovascular Diseases: A Literature Review. J Clin Med. 2025;14(14):4941
DOI: 10.3390/jcm14144941 PMID: 40725634
13. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(9):655
DOI: 10.1016/j.ajic.2008.03.002 PMID: 18538699
14. Jahani-Sherafat S, Razaghi M, Rosenthal VD, Tajeddin E, Seyedjavadi S, Rashidan M, et al. Device-associated infection rates and bacterial resistance in six academic teaching hospitals of Iran: Findings from the International Nocosomial Infection Control Consortium (INICC). J Infect Public Health. 2015;8(6):553-61
DOI: 10.1016/j.jiph.2015.04.028 PMID: 26027477
15. Rabi R, Enaya A, Jomaa DM, Dweekat MZ, Raddad S, Saqfalhait ZT, et al. Catheter-associated urinary tract infections in critical care: Understanding incidence, risk factors, and pathogenic causes in Palestine. PLoS One. 2024;19(8):e0309755
DOI: 10.1371/journal.pone.0309755 PMID: 39213369
16. Sleziak J, Błażejewska M, Duszyńska W. Catheter-associated urinary tract infections in the intensive care unit during and after the COVID-19 pandemic. BMC Infect Dis. 2025;25(1):595
DOI: 10.1186/s12879-025-10996-2 PMID: 40275182
17. Al-Amri HA, Almalhan LA, Alghamdi MA, Ibrahim ME. Catheter-associated urinary tract infection and associated factors among patients admitted to intensive care unit at King Abdullah Hospital, Bisha, Saudi Arabia. BMC Infect Dis. 2025;25(1):1640 DOI: 10.1186/s12879-025-12061-4 PMID: 41286652
18. Zhang G, Cheng Y, Hu X, Li W, Sun J, Chen Z, et al. Microbial etiology of hospital-acquired pneumonia/ventilator-associated pneumonia in hospitals of Shandong Province. J Infect Dev Ctries. 2025;19(9):1336-1344
DOI: 10.3855/jidc.21118 PMID: 41060727
19. Melsen WG, Rovers MM, Groenwold RH, Bergmans DC, Camus C, Bauer TT, et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis. 2013;13(8):665-71
DOI: 10.1016/S1473-3099(13)70081-1 PMID: 23622939
20. Ziegler MJ, Pellegrini DC, Safdar N. Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis. Infection. 2015;43(1):29-36
DOI: 10.1007/s15010-014-0689-y PMID: 25331552
21. Chant C, Smith OM, Marshall JC, Friedrich JO. Relationship of catheter-associated urinary tract infection to mortality and length of stay in critically ill patients: a systematic review and meta-analysis of observational studies. Crit Care Med. 2011;39(5):1167-73
DOI: 10.1097/CCM.0b013e31820a8581 PMID: 21242789
Downloads
Published
Issue
Section
License
Copyright (c) 2026 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



